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Abstract
Background/Objectives—Determine the prevalence of muscle weakness using the two 2014 
Foundation for the National Institutes of Health (FNIH) Sarcopenia Project criteria and its 
relationship to physical limitations, basic and instrumental activities of daily living (ADL).
Subjects/Methods—We performed a cross-sectional analysis of community-dwelling adults 
from the Health and Retirement Study 2006-2008 and identified a subsample of 5,092 adults aged 
≥60 years with grip strength data. Self-reported physical limitations, basic and instrumental 
activities of daily living (ADL) were assessed. Criteria for grip strength (GS) (men<26kg; women 
<16kg), and GS adjusted for body mass index (GS/BMI) (men <1.0; women <0.56) were applied 
to the sample. We determined prevalence of muscle weakness in each sex. Multivariable logistic 
regression was used to calculate the association of physical limitations, basic and instrument 
ADLs with weakness definitions e in each sex.
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Results—Mean age was 72.1 years (54.9% female).Mean GS was 38.3 and 22.9 kg and mean 
BMI was 29 kg/m2, respectively in males and females. Weakness prevalence using GS and 
GS:BMI definitions were 7.8 and 15.2 (p<0.001), respectively in males, and 11.4 and 13.3% 
(p=0.04), in females. Overall prevalence of physical limitations, basic and instrumental ADL 
limitations was 52.9%, 28.1%, and 35.9%. In those with weakness, prevalence of physical 
limitations, basic ADL and instrumental ADL was 78.5%, 42.3% and 65.3% using the GS 
definition, and 79.7%, 40.7%, and 58.8% using the GS/BMI definition. GS and the GS/BMI 
definitions of weakness were strongly associated with physical limitations (OR 2.19 [95%CI:
1.67-2.87] and 2.52 [2.01-3.17]), basic ADL (OR 1.59 [1.22-2.07] and 1.66 [1.32-2.07]), and 
instrumental ADLs (OR 1.98 [1.28-2.54] and 1.78 [1.44-2.20]).
Conclusions—The new FNIH guidelines for weakness are associated with higher prevalence of 
physical limitations basic and instrumental ADL impairments as compared to individuals without 
weakness
Keywords
obesity; diagnostic accuracy; body mass index; body fat; epidemiology; Sarcopenia; Elderly; 
weakness epidemiology; Health & Retirement Study
INTRODUCTION
Age-related muscle loss begins in the third to fourth decade of life1. Though some loss of 
muscle and strength, termed sarcopenia, is a normal part of aging, clinically significant 
sarcopenia associated with functional impairment is thought to be a cornerstone in the 
process of frailty and disability1. While weakness was initially considered to be a direct 
consequence of the loss of muscle mass 2, it may also be mediated through loss muscle 
strength 3, 4. Emerging evidence suggests there may be two distinct subgroups of persons 
with weakness: one due to low appendicular muscle mass, and the other due to reduced 
strength with intact muscle mass5.
There have been considerable discrepancies in the definitions of sarcopenia in the 
literature 6, 7 largely due to the different etiologies of clinical weakness. Recently, the 
Foundations for the National Institutes of Health (FNIH) published criteria for sarcopenia 
specifically for use in clinical practice5 to identify individuals that consisted of using muscle 
strength and muscle mass. This group based their cutoffs on a classification and regression 
tree analysis using grip strength to predict slow gait speed, a clinical measure known to 
strongly predict incident disability and mortality8. Grip strength cutpoints were based on 
eight pooled studies in men and women9. Our goal was to a) illustrate the prevalence of 
clinically defined weakness in a representative population, by applying these new 
recommendations to a wave of subjects from the Health and Retirement Study; b) observe 
the degree of impairment in those fulfilling such cutoffs; and c) describe the association 
between the FNIH cutoffs and physical limitations, basic and instrumental ADL impairment.
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The Health and Retirement Study (HRS) is a nationally representative survey of community-
dwelling adults aged 50 years and older conducted by the University of Michigan. The initial 
HRS sample was drawn in 1992 from a multi-stage, clustered area probability design of 
households, with individuals with birth years between 1931-1941. Data from the 2006 and 
2008 waves were combined for this particular cross-sectional analysis10. All eligible 
respondents consenting to enhanced face-to-face interviews were included in the analysis. 
Study design and sampling procedures are available online (http://hrsonline.isr.umich.edu). 
The study has been funded by the National Institutes on Aging, and due to the de-identified 
nature of the data, the local Institutional Review Boards of our institutions have exempted 
this study from review purposes.
There were 10,615 participants aged ≥60 who consented to the enhanced face to face 
interview. Respondents were excluded if grip strength, or BMI were missing (n=5,523). Our 
final analytical sample consisted of 5,092 subjects. We included persons of all races and 
ethnicities. Years of education and smoking status were obtained by self-report 
questionnaire. We created a co-morbidity index ranging from 0 to 8, which was meant to 
reflect self-reported health conditions, including, cancer, diabetes, heart failure, 
hypertension, lung disease, arthritis, myocardial infarction, and stroke11. Physical activity 
was assessed using a questionnaire during the HRS interview, details of which are described 
online. Subjects were classified as being physically active if they engaged in moderate or 
vigorous physical activity at least once per week.
Measures
Weight was measured using a Healthometer 830KL (Medstock, Australia) scale and rounded 
to the half pound, and converted to kilograms. HRS did not measure subjects with a weight 
>136.4kg, as this exceeded the capacity of the scale. Height was measured using a 
stadiometer with the respondent standing without shoes or socks and their heels and 
shoulders touching the wall. Body mass index (BMI) was calculated as weight (in 
kilograms) divided by height, in meters squared. Waist circumference (WC) was assessed 
using a tape measure at the level of the umbilicus while standing. The measure was recorded 
at the end of exhalation after a deep breath. High WC was determined using cutoffs of 88 cm 
and 102 cm in females and men, respectively12. Walking speed was used as a marker in the 
FNIH criteria. In HRS, it was measured in meters per second and measured as respondents 
walked a 98.5 inch course two times (there and back). Participants were instructed to wear 
appropriate footwear (low or no heal), and the interviewer walked to the side and slightly 
behind the respondent. The measure could be completed with a walking aid. The interview 
used a stop watch to time the respondent.
Grip strength (GS) was measured using a Smedley spring-type hand dynamometer (TTM, 
Tokyo, Japan). In right handed individuals, values from the dominant hand were used. In the 
case of ambidextrous and left-handed individuals, the higher of the values from either hand 
was used13. All measurements were taken with the subject in a standing position, with their 
arm at their side at a 90° angle. Two measurements were taken with each hand and averaged 
across trials. The highest average score from either hand was used. We classified subjects as 
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having weakness based on the 2014 FNIH Sarcopenia Project guidelines5. A GS<26kg and 
<16kg were considered as having weakness in men and women, respectively. As this 
consensus group suggested two independent definitions, we also classified subjects as 
having weakness if their GS divided by BMI ratio (GS/BMI) was <1.0 and <0.56 in males 
and females, respectively.
Functional impairment was assessed using self-reported questionnaires classifying the 
subject’s ability in terms of physical limitations, basic activities of daily living (ADL) and 
instrumental ADL. Physical limitations were defined by the inability or difficulty in 
performing two or more of the following tasks, as described in our previous publication11: 
walking several blocks, walking 1 block, sitting 2 hours, getting up from a chair, climbing 
stairs, climbing one flight of stairs, stooping, reaching arms, pulling or pushing large 
objects, lifting weights or picking up a dime. Individuals with one or more difficulties in 
bathing, dressing, eating, toileting, or getting out of bed were considered to have an ADL 
limitation. Lastly, subjects reporting difficulties with at least one of the following were 
considered to have an instrumental ADL limitation: managing money, preparing meals, 
requiring help with house or yard work, using the phone or taking medications.
Statistical Analysis
Continuous variables are presented as means (standard errors), and categorical values as 
counts (%). T-tests compared baseline characteristics between sexes for continuous 
variables, and chi-square for categorical variables. Subjects were classified as having 
weakness using the aforementioned definitions. Overall and sex-specific prevalence 
estimates of weakness are presented for both FNIH definitions, and a t-test compared the 
mean differences between them. We stratified these results by ethnicity (white, black and 
other), and by three age categories (60-69.9 years, 70-79.9 years, and ≥80 years). Prevalence 
of overall and sex-specific physical impairments (physical limitations, basic and 
instrumental ADL limitations) were determined for the overall cohort, and by ethnicity and 
age-group. The prevalence of limitations by weakness status was evaluated using each 
definition.
The primary aim of this study was to determine the association of the two FNIH definitions 
of weakness (GS and GS/BMI) and physical limitations, basic ADL limitations, and 
Instrumental ADL limitations. Overall and sex-specific unadjusted and adjusted logistic 
regression models were constructed to ascertain the association of each definition with 
degree of impairment. We adjusted for age, race, number of years of schooling completed, 
smoking status, co-morbidity, and physical activity status. For the overall cohort, we 
adjusted for sex as well. Odds ratios and 95% confidence intervals are presented. We 
determined the relationship between walking speed in those with and without weakness 
based on each respective sarcopenia definition, stratified by sex, ethnicity and age group. All 
data was managed and processed using SAS software version 9.3 (SAS Institute, Cary, NC), 
and results were weighted using HRS respondent-level weights for physical measures which 
includes adjustments for sample selection probability and non-response. A p-value <0.05 
and confidence intervals excluding 1.0 were considered statistically significant.
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Baseline characteristics are shown in Table 1. Differences were observed in most 
characteristics between males and females. Grip strength (GS) and walking speed differed 
between sexes (p<0.001), as were the mean number of physical limitations. Table 2 
represents the prevalence of weakness based on FNIH criteria of reduced GS and reduced 
GS:BMI ratios in the overall cohort, by ethnicity and by age group. Overall prevalence rates 
using GS were higher in females than in males (11.4 vs. 7.8%; p<0.001) but higher in males 
(15.2 vs. 13.3%; p=0.05) using GS:BMI. This was generally seen across ethnic and age 
categories. Stratifying by sex, prevalence rates were generally higher using GS:BMI than 
GS. Notably, the prevalence of weakness increased with age.
We determined the prevalence of physical limitations, basic ADL and Instrumental ADL 
limitations by overall cohort, sex, ethnicity and by age group. The prevalence of physical 
limitations in men was 44.7% and in females was 59% (Table 3). Higher prevalence rates of 
physical limitations, basic ADL, instrumental ADL were observed in blacks and by 
increasing age. Figure 1 represents the prevalence of limitations in men and women in those 
with weakness, depending on the definition used. The prevalence rates in both sexes suggest 
that rates of physical limitations are highest in those with weakness (irrespective of 
definition) followed by instrumental ADL and basic ADL impairments. Mean walking speed 
was uniformly lower in those with weakness, irrespective of the FNIH definition, sex, 
ethnicity and age (Figure 2 and Appendix 1). Analysis of individuals excluded in this study 
were less likely to be white, had higher comorbidity burden, higher WC and higher mean 
number of physical limitations (Appendix 2). Full details of sub-analyses can be seen in 
Appendix 3. We additionally present crude data on the relationship between BMI, grip 
strength and limitations by sex in Appendix 4. A bimodal relationship occurs between BMI 
and limitations with higher rates in underweight and obese individuals, while the 
relationship between GS and BMI appears more linear.
Univariate and multivariate analyses are shown in Table 4. The strength of association across 
all limitations (physical, instrumental and basic ADL) was higher in those with sarcopenia. 
The strengths of association were higher in females in physical limitations, lower in 
instrumental ADL. Minimal differences were observed between sexes in basic ADLs. We 
observed reduced odd ratios after adjusting for all of our covariates across all models.
DISCUSSION
We demonstrate that the prevalence of clinical weakness is high in a representative 
population but differ by sex and by FNIH definition used. Our results confirm that the rates 
of limitations are higher in individuals with weakness, irrespective of the definition used. We 
also observed that a strong association exists between weakness and limitations, more so in 
females than in males.
FNIH definitions are meant to identify those at risk for weakness5. The study results were 
readily apparent using the GS:BMI ratio than the GS alone, paralleling those observed using 
the FNIH muscle mass cutpoints alone in our other work14. While both definitions have 
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been used to classify sarcopenia, a shift from using muscle mass to muscle strength (using 
grip strength) has been advocated as the prime determinant for studying sarcopenia. This is 
in direct contrast to the FNIH consensus suggesting that GS was the best predictor in men, 
and GS/BMI was better in women in terms of model fit statistics. We believe that GS:BMI 
accounts for both strength and in part muscle mass and that this measure should be 
considered in clinical practice for identification of sarcopenia. Previous research has also 
suggested different associations between strength and mobility across BMI15 requiring the 
need to adjust for this measure. While BMI traditionally has been used for assessment of 
obesity, in older adults, it has low sensitivity for measuring fat, and that the measure also 
accounts for muscle mass. No consistent trends were observed in basic or instrumental 
ADLs across definitions, likely because these definitions are meant to identify individuals at 
risk for impairments rather than impairments themselves.
Sex-specific differences have been observed in other studies5, 10, 14, including a mortality 
analysis in older adults14. Part of this reasoning is due to sex-specific differences of 
normative population-based data for grip strength15-17. Our data suggests that physical 
limitations and instrumental ADL in those with classified weakness (irrespective of 
definition), was markedly higher in females than in males. While purely hypothetical, 
women tend to gain more fat and have lower absolute muscle mass with age, placing them at 
a greater risk of developing obesity and lower muscle strength with aging4, 18. Consequences 
of obesity in women may be more significant than in men because of greater loss of existing 
lower muscle stores leading to incremental limitations in movement. Further, the female 
population had high central adiposity which can be associated with higher degrees of 
functional impairment.
There are several significant limitations in this study. First, information on chronic illnesses, 
smoking status, race, and physical limitations were all obtained by self-report, which has the 
potential for inaccuracies. Second, sampling bias is likely and may impact our results despite 
the survey’s intention to be a representative sample of older adults. Third, we created a co-
morbidity score incorporating the number of disorders, each of which was given an equal 
weighting. However, we deliberately presented our unadjusted results which suggested that 
the odds ratios remained significant. Fourth, we analyzed a cross-sectional cohort of 
persons. Fifth, our cohort was predominantly white, making generalizations to other races 
very difficult. We presented data on black and other as an exploratory analysis, however, we 
recognize that drawing definitive conclusions is not possible and should be interpreted with 
caution. There are ethnic-differences in body composition, which may explain some of the 
discordance in our results. The FNIH studies were based predominantly on Caucasian 
subjects, although there were subgroups examined that consisted of African-American and 
Hispanic origin. Recalibration of cutpoints and definitions may be needed for these groups, 
paralleling the approach used in the Framingham Risk score or Metabolic Syndrome19. 
Sixth, we defined physical limitations, basic and instrumental ADL using composite scores 
in line with our previous analyses11. This could introduce bias in classifying limitations and 
impact our estimates observed in Table 4. Seventh, this population is a well-functioning, 
community-dwelling, older adult population that may not be typically representative of those 
in this age range. Eighth, there may be selection bias based on a survival effect in clinical 
studies in those over the age of 80 years may be relatively healthier. Lastly, we recognize 
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that there were a number of participants we excluded which could bias our results. However, 
an attempt was made to compare the characteristics of participants included and those 
excluded. The use of HRS respondent level weights for the sub-analysis (that contains 
adjustments for non-response) helped account for the potential bias(http://
hrsonline.isr.umich.edu/modules/meta/tracker/desc/
PMWeight2004_Description_public.pdf).
While the thresholds focus on weakness and function, those with weakness and obesity were 
not adequately categorized. In the absence of body composition data, this cannot be 
determined using this dataset. With over 35% of the older adult population having obesity20, 
the implications of muscle weakness in this subgroup of should not be overlooked. In both 
cross-sectional21 and longitudinal studies22, loss of muscle mass and weakness are 
associated with impairments in function. A major limitation of this current analysis is the 
inability to formally assess body fat nor the ability to assess muscle mass, a core component 
of the sarcopenia definition.
Cut-points are based and determined by their referent populations, all of which may have 
differing physical and functional characteristics. When applying different thresholds for a 
variable (ie: grip strength), altering a cutoff may dramatically alter prevalence. Further, grip 
strength is a continuous variable and its relationship with impaired function, disability, and 
mortality is based on this structure. Dichotomizing GS into low vs. normal may impact those 
who are slightly above the threshold, yet their long-term risk may modestly be increased 
versus a counterpart just below this threshold. The potential for overdiagnosis (or 
underdiagnosis) of a clinical condition is possible.
To our knowledge, this is the first study to apply the FNIH criteria for weakness to the 
Health and Retirement Study. While sarcopenia (and its components) is generally 
recognized in the geriatric literature, it is only increasingly being appreciated in the general 
medical community and in the primary care setting. Identification of individuals at risk for 
weakness allows for targeted interventions in the care setting and implementation of care 
planning for those at risk of frailty23. Our results suggest that irrespective of the definition 
used, the association with impairment is evident. Recognition will allow prevention of the 
condition and its consequences, in addition to treatment of those with existing functional 
impairments. Only with standardized measures for identification will evaluation of proposed 
sets of outcomes, including patient-reported outcomes, utilization and serious injury could 
be performed. BMI is measured routinely in clinical settings and integrating GS may be 
more practical and cost-effective than gait speed or other functional measures. However, 
future studies should determine the balance between diagnostic accuracy and practical 
incorporation in busy clinical practices.
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ADL Activities of Daily living
BMI Body mass index
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Prevalence of Impairments (Physical Limitations, Basic Activities of Daily Living and 
Instrumental Activities of Daily Living) in subjects with weakness aged ≥60years in the 
Health and Retirement Survey 2006-2008, based on the Foundation for the National 
Institutes on Health Sarcopenia Project Guidelines
p-values represent the differences between Grip strength and grip strength:body mass index 
definitions.
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Mean Walking Speed in Subjects with and without Sarcopenia aged ≥60years in the Health 
and Retirement Survey 2006-2008, based on the Foundation for the National Institutes on 
Health Sarcopenia Project Guidelines. Error bars represent standard deviations
P-values represent the differences between individuals with and without weakness 
(depending on the definition used)
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Table 1








Age, years 72.1 (7.9) 71.9 (7.5) 72.1 (8.1) .37
Education, years 12.4 (3.1) 12.6 (3.3) 12.3 (2.9) <.001
Race
 White 4308 (84.6) 1901 (86.6) 2407 (83.1) <.001
 Black 619 (12.2) 272 (10.1) 397 (13.7) <.001
 Other 165 (3.2) 72 (3.3) 93 (3.2) .10
Current Smoker (%) 582 (11.4) 259 (11.8) 323 (11.2) <.001
Number of Comorbidities
d 2.02 (1.21) 2.0 (1.3) 2.1 (1.2) <.01
Grip Strength, kg 29.5 (10.6) 38.3 (9.1) 22.9 (5.8) <.001
Walking Speed, m/s
a 2.46 (0.86) 2.61 (0.85) 2.34 (0.84) <.001
Waist Circumference, cm 100.3 (14.0) 104.7 (11.5) 96.9 (14.7) <.001
High Waist Circumference (%)
b 3229 (63.4) 1200 (54.7) 2029 (70.0) <.001
Body Mass Index, kg/m2 28.7 (5.5) 28.9 (4.7) 28.7 (6.0) .20
Obesity, BMI≥30kg/m2 1849 (36.7) 790 (36.1) 1059 (37.2) <.001
Mean number of Physical <.001
Limitations 2.5 (2.5) 1.9 (2.26) 2.9 (2.6)
Physically Active
c 3062 (60.2) 1451 (66.2) 1611 (55.7) <.001
All values represented are means (standard deviation) or counts (percentages)
a
Walking speed was available for 3,849 participants
b
≥88cm in females; ≥102cm in males
c
Physically Active was defined as participation in moderate/vigorous activity at least 1 per week.
d
Comorbidities (hypertension, diabetes, lung disease,stroke,cancer, MI,CHF and arthritis)
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